Mark Ahern

Mark is a proven industry leader in building early-stage healthcare companies by developing and executing revenue growth plans to build best-in-class healthcare organizations. He is known for working effectively with CEOs, key stakeholders, and boards to define and create growth initiatives, strategic alignments, and successful exit strategies. Most recently, Mark was the Chief Development Officer at US Oncology McKesson, where he led their business development efforts. Prior to McKesson, Mark led all aspects of business development for Vantage Oncology prior to its sale to McKesson.